{"id":155815,"date":"2021-07-20T01:52:41","date_gmt":"2021-07-20T05:52:41","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/japan-becomes-first-country-to-approve-ronapreve-casirivimab-and-imdevimab-for-the-treatment-of-mild-to-moderate-covid-19\/"},"modified":"2024-08-18T11:43:21","modified_gmt":"2024-08-18T15:43:21","slug":"japan-becomes-first-country-to-approve-ronapreve-casirivimab-and-imdevimab-for-the-treatment-of-mild-to-moderate-covid-19","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/japan-becomes-first-country-to-approve-ronapreve-casirivimab-and-imdevimab-for-the-treatment-of-mild-to-moderate-covid-19.php","title":{"rendered":"Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate COVID-19"},"content":{"rendered":"<p><![CDATA[Basel, 20 July 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that Japan\u2019s Ministry of Health, Labour and Welfare (MHLW) has approved Ronapreve\u2122(casirivimab and imdevimab), for the treatment of patients with mild to moderate COVID-19 via intravenous infusion. The antibody combination was granted a Special Approval Pathway under article 14-3 of the Pharmaceuticals and Medical Devices Act.]]><\/p>\n<p>Follow this link:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"https:\/\/www.globenewswire.com\/news-release\/2021\/07\/20\/2265277\/0\/en\/Japan-becomes-first-country-to-approve-Ronapreve-casirivimab-and-imdevimab-for-the-treatment-of-mild-to-moderate-COVID-19.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate COVID-19\">Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate COVID-19<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Follow this link: Japan becomes first country to approve Ronapreve (casirivimab and imdevimab) for the treatment of mild to moderate COVID-19 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/japan-becomes-first-country-to-approve-ronapreve-casirivimab-and-imdevimab-for-the-treatment-of-mild-to-moderate-covid-19.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-155815","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/155815"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=155815"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/155815\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=155815"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=155815"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=155815"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}